Valuation

Valuation of IP is familiar to every investor in the biotech sector and careful due diligence is essential before putting money at risk. We...

Everyone’s happy to talk about how important talent is to tech and life sciences companies but when it comes to valuation the financial community...

2014 saw VCs plough $6.55bn into the biotech sector, with Europe alone seeing a year-on-year increase of $1.24bn. The figures tell a story of...